GRO Biosciences
Cambridge, Massachusetts, United States · Biotechnology, Health Care, Therapeutics · 200 employees
GRO Biosciences is an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics. The company is transforming treatments in diverse areas including autoimmune and metabolic diseases to improve the lives of patients. GRO Biosciences is applying its platform to advance partnered and collaborative programs, as well
Funding history
- Funding Round — $27.4M — Jul 2024
- Series series b — $60.3M — Jul 2024
Recent signals
- Jul 25, 2024: Raised $27.4M
- Jul 19, 2024: Raised $60.3M in Series series b
- Mar 18, 2024: GRO Biosciences Hires Tracey Lodie, PhD as Chief Development Officer
See plans & pricing → Track GRO Biosciences’s funding, hiring, and signals — with verified contacts — on Fundz.